Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-Administration of HA and TXA in Facial Filler
NCT04373603Phase 4Withdrawn
- Sponsor
- University of Wisconsin–Madison
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in injection site bruising (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Intensity of Bruising Score at 7 days. Planned start Jul 2022; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
injection site bruising
Beyond the preview
Go deeper on NCT04373603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373603.